GlassScriptPhysician profile
Anu G Desai
NPI 1013125079
$4,480.08
in general payments reported to CMS, 2019-2025
22 companies · $1,457 in 2025
The $1,457 reported for 2025 was more than what 84% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,614 · 2020: $326 · 2021: $268 · 2022: $274 · 2023: $221 · 2024: $320 · 2025: $1,457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,998.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $1,338.21 | 2019-2023 | Tecnis Iol |
| Lumenis Be INC | $707.89 | 2025 | M22 |
| Alcon Vision LLC | $403.79 | 2020-2025 | Clareon, Clareon Panoptix Pro, Tryptyr |
| Glaukos Corporation | $312.40 | 2020-2025 | Istent Trabecular Micro-Bypass System Model Is3, Istent Infinite Trabecular Micro-Bypass System Model Is3, Idosetr |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $271.13 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $183.57 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $166.49 | 2019-2025 | Cequa |
| Dompe US, INC. | $164.42 | 2021-2025 | Oxervate |
| Mallinckrodt Hospital Products INC. | $147.75 | 2021-2023 | Acthar |
| Allergan, INC. | $124.71 | 2019 | |
| Abbvie INC. | $123.24 | 2022-2024 | Durysta |
| Bausch & Lomb Americas INC. | $109.74 | 2023-2025 | Miebo, Xiidra, Envista Mx60 Iol |
| Ocular Therapeutix, INC. | $82.43 | 2022-2025 | Dextenza |
| Biotissue Holdings INC. | $68.63 | 2019-2023 | |
| Oyster Point Pharma, INC. | $58.57 | 2022-2025 | Tyrvaya, Ryzumvi |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $52.24 | 2022 | |
| Sight Sciences, INC. | $48.42 | 2025 | Sion Surgical Instrument, Omni Surgical System |
| Harrow Eye, LLC | $32.37 | 2025 | Vevye |
| Astellas Pharma US INC | $27.62 | 2024 | Izervay |
| Rayner Intraocular Lenses Limited | $27.28 | 2025 | Rayone Aspheric, Rayner Cataract Set 1, Rayone Emv |
| Rxsight INC | $17.22 | 2025 | Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal), Rxsight Contact Lens |
| New World Medical,INC. | $11.96 | 2025 | Ahmed Glaucoma Valve, Kahook Dual Blade, Clearpath |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anu Desai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.